From: Epithelial-myoepithelial carcinoma: a population-based survival analysis
T | ||
T1 | 102 | 21.8% |
T1a | 3 | 0.6% |
T1c | 2 | 0.4% |
T2 | 101 | 21.6% |
T3 | 46 | 9.8% |
T3a | 1 | 0.2% |
T3b | 1 | 0.2% |
T3c | 6 | 1.3% |
T3x | 1 | 0.2% |
T4 | 2 | 0.4% |
T4a | 13 | 2.8% |
T4b | 4 | 0.9% |
TX | 28 | 6.0% |
TXa | 2 | 0.4% |
unknown | 156 | 33.3% |
N | ||
N0 | 269 | 57.5% |
N1 | 16 | 3.4% |
N1x | 2 | 0.4% |
N2 | 1 | 0.2% |
N2NOS | 1 | 0.2% |
N3 | 1 | 0.2% |
NX | 22 | 4.7% |
unknown | 156 | 33.3% |
M | ||
M0 | 286 | 61.1% |
M1 | 12 | 2.6% |
MX | 14 | 5.2% |
unknown | 156 | 33.3% |